Alamar Capital Management LLC Sells 91 Shares of Intuitive Surgical, Inc. $ISRG

Alamar Capital Management LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The firm owned 4,269 shares of the medical equipment provider’s stock after selling 91 shares during the quarter. Alamar Capital Management LLC’s holdings in Intuitive Surgical were worth $2,320,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. boosted its stake in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp boosted its stake in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP boosted its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC bought a new position in Intuitive Surgical in the 1st quarter worth about $1,715,899,000. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have commented on ISRG. Erste Group Bank restated a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. Wall Street Zen downgraded Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Sanford C. Bernstein reiterated an “outperform” rating and set a $685.00 price target on shares of Intuitive Surgical in a research report on Tuesday. Mizuho set a $575.00 price target on Intuitive Surgical in a research report on Wednesday. Finally, Leerink Partners lifted their price target on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research report on Wednesday. Eighteen analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $604.50.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $551.30 on Friday. The business’s 50 day simple moving average is $456.77 and its two-hundred day simple moving average is $496.40. The stock has a market capitalization of $197.63 billion, a P/E ratio of 72.92, a price-to-earnings-growth ratio of 5.53 and a beta of 1.61. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion for the quarter, compared to analysts’ expectations of $2.41 billion. During the same period in the previous year, the firm earned $1.84 EPS. The business’s quarterly revenue was up 22.9% on a year-over-year basis. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of the company’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares of the company’s stock, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares in the company, valued at $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 40,724 shares of company stock worth $19,500,332 over the last 90 days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.